References
- Alam A N, Saha J R, Dobkin J, Lindenbaum F. J. Interelhnic variation in the metabolic inactivation of digoxin by the gut flora. Gastroenterology 1988; 95: 117–123
- Allison M J, Cook M H, Milne D B, Gallagher S, Clayman R V. Oxalate degradation by gastrointestinal bacteria from humans. Journal of Nutrition 1986; 116: 455–460
- Allison M J, Dawson K A, Maybery W R, Foss J G. Oxalobacter fornugenes, gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract. Archives of Microbiology 1985; 141: 1–7
- Arabi Y, Dimock F, Burdon D W, Alexander-Williams J, Keighley M RB. Influence of bowel preparation and antimicrobials on colonic microflora. British Journal of Surgery 1978; 65: 555–559
- Argenzio R A, Liacos J A, Allison M J. Intestinal oxalate-degrading bacteria reduce oxalate absorption and toxicity in guinea pigs. Journal of Nutrition 1988; 118: 787–792
- Beck D E, Harford F J, DiPalma J A. Comparison of cleansing methods in preparation for colonic surgery. Diseases of the Colon and Rectum 1985; 28: 491–495
- Bentley D W, Nichols R L, Condon R, Gorbach E. SL. The microflora of the human ileum and intraabdominal colon: results of direct needle aspiration at surgery and evaluation of the technique. Journal of Laboratory and Clinical Medicine 1972; 79: 421–429
- Bryant M P, Burkey L A. Cultural methods and some characteristics of the more numerous groups of bacteria in the bovine rumen. Journal of Dairy Science 1953; 36: 205–217
- Butler V P, Tse-Eng D, Lindenbaum J, Kalman S M, Preibisz J J, Rund D G, Wissel P S. The development and application of a radioimmunoassay for dihydrodigoxin, a digoxin metabolite. Journal of Pharmacology and Experimental Therapeutics 1982; 221: 123–131
- Cummings J H, Pomare E W, Branch W J, Naylor C P, MacFarlane G T. Short chain fatty acids in human large intestine, portal hepatic and venous blood. Gut 1987; 28: 1221–1227
- Daniel S L, Hartman P, Allison A. MJ. Microbial degradation of oxalate in the gastrointestinal tracts of rats. Applied and Environmental Microbiology 1987; 53: 1793–1797
- Doane L T, Liebman M, Caldwell D R. Microbial oxalate degradation: effects on oxalate and calcium balance in humans. Nutrition Research 1991; 9: 957–964
- Dobkin J F, Saha J R., Butler V PJ, Neu H C, Lindenbaum J. Digoxin-inactivating bacteria: identification in human gut flora. Science 1983; 220: 325–327
- Edmiston C E, Avant G R, Wilson F A. Anaerobic bacterial populations on normal and diseased human biopsy tissue obtained at colonoscopy. Applied and Environmental Microbiology 1982; 43: 1173–1181
- Hartley C L, Neumann C S, Richmond M H. Adhesion of commensal bacteria to the large intestine wall in humans. Infection and Immunity 1979; 23: 128–132
- Anaerobic Laboratory Manual, L V Holdeman, E P Cato, W EC Moore. VPI Anaerobe Laboratory, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 1977
- Lindenbaum J, Rund D G, Butler V P, Tse-Eng D, Saha J R. Inactivation of digoxin by the gut flora: reversal by antibiotic therapy. New England Journal of Medicine 1981; 305: 789–794
- Lindenbaum J, Tse-Eng D, Butler V P, Rund D G. Urinary excretion of reduced metabolites of digoxin. American Journal of Medicine 1981; 71: 67–74
- Lindenbaum J, Whitlock M E, Dobkin J R, Weaver G. Gastrointestinal site of bacterial inactivation of digoxin in humans and rats. Microecology and Therapy 1987; 17: 83–84
- Mathan V I, Wiederman J, Dobkin J F, Lindenbaum J. Geographic differences in digoxin inactivation, a metabolic activity of the human anaerobic gut flora. Gut 1989; 30: 971–977
- Miller T L, Wolin M J. A serum bottle modification of the Hungate technique for cultivating obligate anaerobes. Applied and Environmental Microbiology 1974; 27: 985–987
- Moore W EC, Cato E P, Holdeman L V. Some current concepts in intestinal bacteriology. American Journal of Clinical Nutrition 1978; 31: S33–S42
- Morotomi M, Guillem J G, Pocsidio J, LoGerfo P, Treat M, Forde K A, Weinstein I B, Watanabe I, Mutai M. Effect of polyethylene glycol-electrolyte lavage solution on intestinal microflora. Applied and Environmental Microbiology 1989; 55: 1026–1028
- Ochs H, Bodem G, Schafer P K, Kodrat G, Dengler H J. Absorption of digoxin from the distal parts of the intestine in man. European Journal of Clinical Pharmacology 1975; 9: 95–97
- Reuning R H, Shepard T A, Morrison B E, Bockbrader H N. Formation of [20R]-dihydrodigoxin from digoxin in humans. Drug Metabolism and Disposition: the Biological Fate of Chemicals 1985; 13: 51–57
- Robertson L W, Chandrasekaran A, Reuning R H, Hui J, Rawal B D. Reduction of digoxin to 20R, -dihydrodigoxin by cultures of Eubacterium lentum. Applied and Environmental Microbiology 1986; 51: 1300–1303
- Rund D G, Lindenbaum J, Dobkin J F, Butler V P. Decreased digoxin cardioinactive-reduced metabolites after administration as an encapsulated liquid concentrate. Clinical Pharmacology and Therapeutics 1983; 34: 738–743
- Weaver G A, Krause J A, Miller T L, Wolin M J. Constancy of glucose and starch fermentation by two different human faecal microbial communities. Gut 1989; 30: 19–25